Clinical Trial Update: First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

First-in-human Phase 1/2 trial of an autologous dendritic cell vaccine targeting Wilms' tumor protein 1 (WT1) with interleukin-15 trans-presentation, studied in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Liver Cancer
• Ovarian Cancer
• Pancreatic Cancer

Drugs mentioned

• Interleukin-15-transpresenting Wilms' tumor protein 1-targeting autologous dendritic cell vaccine

Snippet

Sponsor: University Hospital, Antwerp | Conditions: Esophageal Cancer, Pancreas Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING